Chemoinformaics analysis of RIBOFURANOSYL-CIS-ZEATIN
| Molecular Weight | 351.363 | nRot | 6 |
| Heavy Atom Molecular Weight | 330.195 | nRig | 17 |
| Exact Molecular Weight | 351.154 | nRing | 3 |
| Solubility: LogS | -2.44 | nHRing | 3 |
| Solubility: LogP | -0.501 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 10 |
| nHA | 10 | APOL | 48.5627 |
| nHD | 5 | BPOL | 28.5033 |
| QED | 0.399 |
| Synth | 4.554 |
| Natural Product Likeliness | 1.58 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.981 |
| HIA | 0.97 |
| CACO-2 | -5.453 |
| MDCK | 0.00000619 |
| BBB | 0.675 |
| PPB | 0.252262 |
| VDSS | 0.753 |
| FU | 0.744197 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.113 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.306 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.04 |
| CYP3a4-inh | 0.027 |
| CYP3a4-sub | 0.07 |
| CL | 6.757 |
| T12 | 0.88 |
| hERG | 0.024 |
| Ames | 0.048 |
| ROA | 0.701 |
| SkinSen | 0.094 |
| Carcinogencity | 0.061 |
| EI | 0.01 |
| Respiratory | 0.965 |
| NR-Aromatase | 0.894 |
| Antiviral | Yes |
| Prediction | 0.554677 |